Fred Schulte, with the Investigative Reporting Workshop at American University, reviewed government documents to find that Nancy-Ann DeParle, director of the White House Office of Health Policy, “served as a director of corporations that faced scores of federal investigations, whistleblower lawsuits and other regulatory actions.”
DeParle, who was in the Clinton administration, has earned more than $6.6 million in the private sector since 2001.
After leaving government, DeParle accepted director positions at half a dozen companies suspected of violating the very laws and regulations she had enforced for Medicare. Those companies got into further trouble on her watch as a director.
In the story, published on MSNBC.com, Schulte details DeParle’s many corporation connections, including those with Guidant, Boston Scientific Corp. and DaVita Inc. While the story acknowledges that board members usually aren’t held legally accountable for illegal dealings by a company’s management, it does find that “served on board committees responsible for monitoring the companies’ compliance with laws and regulations.”
